about
Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapyFrequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.Digital breast tomosynthesis: lessons learned from early clinical implementation.A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images.Fully Automated Quantitative Estimation of Volumetric Breast Density from Digital Breast Tomosynthesis Images: Preliminary Results and Comparison with Digital Mammography and MR ImagingAutomated fibroglandular tissue segmentation and volumetric density estimation in breast MRI using an atlas-aided fuzzy C-means methodAsymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines.Multimodality screening of high-risk women: a prospective cohort study.Breast MR imaging: current indications and advanced imaging techniques.Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.Distinguishing lesions from posterior acoustic shadowing in breast ultrasound via non-linear dimensionality reduction.Correlation between quantified breast densities from digital mammography and 18F-FDG PET uptake.Erratum to: Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.Evaluation of proscriptive health care policy implementation in screening mammography.Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.The perception of breast cancer: what differentiates missed from reported cancers in mammography?Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.Invited CommentaryEvolving Role of MRI in Breast Cancer ImagingScreening of Contralateral Breast in Patients with Breast Cancer: Role of MR Imaging and PET/CT ImagingMammographic Appearance of Recurrent Breast Cancer after Breast Conservation TherapyMethod of Primary Tumor Detection as a Risk Factor for Local and Distant Recurrence After Breast-Conservation Treatment for Early-Stage Breast CancerCase 59: Angiolipoma of the BreastEleven-Year-Old With Breast MassFive Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and RoundDigital Breast Tomosynthesis: Concepts and Clinical PracticeBreast Cancer Conspicuity on Simultaneously Acquired Digital Mammographic Images versus Digital Breast Tomosynthesis Images
P50
Q33868006-6732D9E6-D140-471A-AAB6-805C06734FD7Q33922291-28901DEF-0EF3-4426-B5B8-486E317F4287Q35057025-EE01242A-9E6A-4541-A28C-9033B7CAA3B0Q35621559-0E7DC50B-9875-4F85-8F0B-F46538911998Q35899068-B54E745C-DD14-4AF6-B0F8-F49B6B1F6C3AQ36710179-066A4124-14CF-48D8-BC41-588784E8D96BQ36762737-2DD42A7D-C47C-4FDD-BD11-D8DC10B3EAADQ37366252-EE8CD69C-E319-4CA5-BEB2-1C784F3BF5F4Q37379081-686D810F-4471-4B5C-AAB4-9BF205788EF1Q37474357-6F5FE2A9-665F-4994-BAD4-D80B303CB800Q37792265-6E8C639E-E706-4405-95D6-E7A049D638E9Q37973983-9C27EDC2-2C27-4065-A37B-A8985CB8F0F8Q39818079-DB29E900-B6ED-468A-BF09-99452BE91DE7Q39893162-678BEFD3-2A8C-46D8-B437-97CBBCCAF66CQ43156443-DEC7DF36-7C1D-4F30-959D-0F3559D8657DQ46945363-9B8B2155-B19D-4EEC-A397-7D094F2771A7Q47408594-0CDF0787-200E-4191-B4D6-96ABF8B8840AQ51051671-EB2D0390-927F-43DE-8C99-AEA4820A3B34Q52943171-8D7F0378-7C75-4D95-B611-71E97B771C57Q55043174-8A6A53DD-4583-438F-A20E-5EADB9C71988Q63168213-F52E7C36-6ACC-4308-97CF-9D5B8A9CB351Q63168259-1816D7B6-DC3B-4711-A522-5DDD6B51598BQ63168267-31F3EBAE-5250-4A99-A4F6-DEB61C46EE85Q63168270-51F427E5-1749-4F5B-87A1-598215558BADQ63168275-CC03AD55-DF7A-477D-9A16-36AD3153215CQ63168300-75C1E355-0FE5-4CC9-8E21-DB1491DC1EA0Q63168304-F56E7B3A-6808-419F-97F0-727BA04B077FQ90184518-5DF732E3-9C5C-46AC-8456-95932A5FA155Q91988352-F8A190EF-0B14-4B4A-982F-4C3239B7F436Q91988433-8CC25C51-C96B-4059-A49E-576B995FDD16
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susan P Weinstein
@nl
Susan P Weinstein
@sl
Susan P. Weinstein
@en
Susan P. Weinstein
@es
type
label
Susan P Weinstein
@nl
Susan P Weinstein
@sl
Susan P. Weinstein
@en
Susan P. Weinstein
@es
prefLabel
Susan P Weinstein
@nl
Susan P Weinstein
@sl
Susan P. Weinstein
@en
Susan P. Weinstein
@es
P106
P1153
7202467304
P21
P2456
P31
P496
0000-0001-6159-1500